...
首页> 外文期刊>Cardiovascular engineering and technology >Fabrication and Testing of Electrospun Polyurethane Blended with Chitosan Nanoparticles for Vascular Graft Applications
【24h】

Fabrication and Testing of Electrospun Polyurethane Blended with Chitosan Nanoparticles for Vascular Graft Applications

机译:用壳聚糖纳米粒子混合电动梭纳米粒子的制造和测试血管接枝应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, a small vascular graft based on polyurethane (PU) blended with chitosan (Ch) nanoparticles was fabricated using electrospinning technique. Initially, the chitosan nanoparticles were synthesized using ionic gelation method. UV-Vis spectrophotometer confirmed the presence of synthesized Ch nanoparticles by exhibiting absorption peak at 288 nm and the Fourier-transform infrared spectroscopy (FTIR) analysis confirmed the existence of the chitosan. Further, the synthesized Ch nanoparticles showed size diameter in the range of 134 +/- 58 nm as measured using ImageJ. In the electrospun PU/chitosan graft, the fiber diameter and pore size diameter was found to be reduced compared to the pure PU owing to incorporation of chitosan into PU matrix. The FTIR spectrum revealed the presence of chitosan in the prepared nanocomposite membrane by the formation of the hydrogen bond and peak shift of CH and NH stretching. Moreover, the contact angle measurements revealed that the prepared graft showed decreased contact angle indicating hydrophilic nature compared to the pristine PU. The cytocompatibility studies revealed the non-toxic behavior of the fabricated graft. Hence, the prepared graft exhibiting significant physiochemical and non-toxic properties may be a plausible candidate for cardiovascular graft applications.
机译:在该研究中,使用静电纺丝技术制造基于与壳聚糖(CH)纳米颗粒混合的聚氨酯(PU)的小血管移植物。最初,使用离子凝胶化方法合成壳聚糖纳米粒子。 UV-VIS分光光度计通过在288nm处表现出吸收峰并且傅里叶变异红外光谱(FTIR)分析证实了合成的CH纳米颗粒的存在证实了壳聚糖的存在。此外,合成的CH纳米颗粒在使用ImageJ测量的范围内显示在134 +/- 58nm的范围内的尺寸直径。在电纺PU /壳聚糖移植物中,与纯PU相比,纤维直径和孔径直径由于普通普掺入PU基质而减少。 FTIR光谱通过形成CH和NH拉伸的氢键和峰值延伸,显示出在制备的纳米复合膜中存在壳聚糖的存在。此外,接触角测量显示,与原始PU相比,制备的移植物显示出具有亲水性的接触角度降低。细胞偶联性研究揭示了制造移植物的无毒行为。因此,表现出显着的生理化学和无毒性质的制备的移植物可以是用于心血管移植物应用的合理候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号